Related Experiment Video
Updated: May 10, 2026

06:24
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Adherence rates and correlates in long-term hormonal therapy
1School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Vitamins and Hormones
|July 2, 2013
Summary
Adjuvant hormonal therapy improves breast cancer outcomes, but daily oral medication adherence is challenging due to side effects. Interventions are needed to enhance patient adherence for optimal treatment benefits.
Area of Science:
- Oncology
- Pharmacology
- Patient Adherence Research
Background:
- Adjuvant hormonal therapy significantly improves breast cancer outcomes.
- Daily oral medications like tamoxifen and aromatase inhibitors (AIs) are crucial for 5 years of treatment.
- Considerable nonadherence to these therapies occurs, increasing over time.
Purpose of the Study:
- To highlight the challenges in adherence to adjuvant hormonal therapy for breast cancer.
- To emphasize the need for interventions to improve medication adherence.
- To underscore the importance of addressing side effects that hinder adherence.
Main Methods:
- Review of current evidence on adjuvant hormonal therapy adherence.
- Analysis of factors contributing to nonadherence, including side effect profiles.
- Exploration of potential pharmacologic and nonpharmacologic interventions.
Main Results:
- Nonadherence to tamoxifen and AIs is substantial and worsens over time.
- Side effects associated with tamoxifen and AIs are significant barriers to adherence.
- Interventions show potential for improving adherence and managing side effects.
Conclusions:
- Improving adherence to adjuvant hormonal therapy is critical for optimal breast cancer treatment outcomes.
- Further research and development of effective interventions are necessary.
- Addressing treatment side effects is key to enhancing patient adherence.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
Target Cell Response to Hormones
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
